Loading...

Daily General Analysis

July 22, 2026

Hey everyone! I grabbed a triple espresso here at the café, and let's break down what's really moving the market today, July 23, 2026. Let's get straight to the point: I've picked the 4-6 news items that will most impact your portfolio in the coming months. Forget the noise, focus on what matters. --- ### 1. China Dominates Shipyards: New Orders Surge 173% Fact: The Chinese shipbuilding industry (CSSC, for example) posted an all-time record for new orders in the first half of 2026, up 173% year-over-year, gobbling up over 62% of the global market. Effect: I Would Buy the *shipbuilding* and maritime logistics sectors. The order boom guarantees years of revenue. Affected Assets/Sectors: CSSC (China State Shipbuilding Corp), Vale S.A. (VALE3 - iron ore needs ships), maritime shipping (Drewry Shipping Index), steel and heavy plates (Gerdau - GOAU4). ### 2. AMD Signs Billion-Dollar Deal with Anthropic (Challenging Nvidia) Fact: AMD (AMD) signed a multi-hundred-billion-dollar contract with Anthropic to supply AI chips starting in 2027, equivalent to 2 gigawatts of processing power. Effect: I Would Buy AMD. This deal pulls AMD out of Nvidia's (NVDA) shadow and positions it as a key player in AI infrastructure. Affected Assets/Sectors: AMD (AMD), Nvidia (NVDA), semiconductor suppliers (ASML), data centers, and server electricity. ### 3. Neuralink Valued at $42 Billion: Hype or New Frontier? Fact: Investors are valuing Neuralink, Elon Musk's brain-chip startup, at an impressive $42 billion, even before significant revenue. Effect: I Would Hold (or watch from afar). The valuation is too aggressive for a company with no revenue. It's a bet, not an investment. I wouldn't buy, but I'd keep an eye on the neurotechnology sector. Affected Assets/Sectors: Tesla (TSLA - Musk correlation), biotech and medical implant companies, AI and precision medical hardware sectors. ### 4. DEXE Tokens Collapse 80%, Ondo Soars 15%: July Crypto Madness Fact: The DeXe (DEXE) token suffered an exploit and lost 80% of its value in 24 hours, while the Ondo token (ONDO) surged 14.8% with explosive volume. Effect: I Would Sell (or avoid) DEXE. I Would Buy (small position) ONDO, due to volume and resistance breakout. Affected Assets/Sectors: Bitcoin (BTC - sector sentiment), Ethereum (ETH - contract base), DeXe (DEXE), Ondo Finance (ONDO). ### 5. China Approves Innovative Therapy Before US: Global Health Shift Fact: China approved a globally innovative drug for the first time before the US, Japan, and Europe, signaling leadership in biotechnology. Effect: I Would Buy Chinese biotech companies and Asia-focused healthcare ETFs. This move accelerates drug approvals in the Asian giant. Affected Assets/Sectors: WuXi AppTec (603259.SH), iShares MSCI China Health Care ETF, pharmaceutical companies operating in China, research labs. --- ### Immediate Opportunities - Ships & Logistics: Buy shares of Chinese shipbuilders (CSSC) and maritime shipping companies. Commodity demand is set to explode. - AMD (AMD): The Anthropic deal is a game-changer. Get in now before the market prices it in. - Ondo Finance (ONDO): If you have the stomach for crypto, the resistance breakout with high volume is a bullish signal. - Chinese Biotech: China-focused healthcare ETFs are cheap. Accelerated drug approvals will turbocharge the sector. ### Risks on the Radar - Crypto Exploit (DEXE): The DEXE collapse shows the token market is full of pitfalls. Stay away from projects with little auditing. - AI Overvaluation (Neuralink): Early-stage companies with $42 billion valuations can create a bubble. Beware the herd mentality. - Commodity Dependence: The Chinese shipbuilding boom depends on steel and iron ore prices. Any Chinese slowdown could flip the script. --- Source Links: Shipbuilding China record | AMD + Anthropic deal | Neuralink $42B valuation | DEXE collapse | ONDO rally | China drug approval breakthrough --- *This analysis is personal opinion and does not constitute investment advice.*

Related News

First Step

Welcome

By signing up, you declare that you agree to our terms of use and privacy policies.
Opportunities Today

Enjoy

Your Passport to Global Investments

Ivar recommends Swissquote bank for your international investments. By opening your account through the link below and trading 5 lots or more, you will receive $200 to use on Ivar AI and activate your subscription. Take advantage of this exclusive offer available today!

Swissquote

Offer available for you who have not yet opened your account at Swissquote.
Services available globally except for the following countries: Algeria, Belgium, Canada, China, North Korea, USA, France, Hong Kong, Iran, Iraq, Nigeria, Singapore, Syria, Turkey and Zimbabwe.